FDA Tries To Tame Antitrust Wars Over Dangerous-Drug Sales
The U.S. Food and Drug Administration took fresh action Thursday to assure manufacturers of brand-name drugs they won't be punished for selling medications requiring special safety controls to generic-drug makers, but...To view the full article, register now.
Already a subscriber? Click here to view full article